NA
SCLN

Navellier & Associates’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Navellier & Associates’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26,032
Closed -$286K – 337
2017
Q2 		$286K Sell
26,032
-4,407
-14% -$48.4K 0.04% 248
2017
Q1 		$298K Buy
30,439
+2,614
+9% +$25.6K 0.04% 247
2016
Q4 		$301K Buy
27,825
+13,499
+94% +$146K 0.05% 229
2016
Q3 		$147K Buy
+14,326
New +$147K 0.02% 244